Neoadjuvant Combination Treatment of Olaparib and Pembrolizumab for Patients with HRD-positive Advanced Ovarian Cancer.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined